IMAX Corporation IMAX

Movie theater chain Cinemark and premium projector maker IMAX are in buy ranges, as they look to extend this year's robust stock gains

AMC stock is bleeding out a big chunk of its prior-session surge while Cinemark and IMAX barely flinch, and that split tells you something important about who is actually driving the selling.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IMAX (NYSE:IMAX) and the rest of the media & entertainment stocks fared in Q2.

Third-quarter domestic box office collections have crossed $3 billion, a new record for the three-mo

AMC stock is surging on a multibillion-dollar refinancing package while its theater peers barely budge, and the gap between them points to a high-stakes bet that hinges on terms the company has yet to reveal.

Morgan Stanley reportedly sees IMAX’s growing screen network and stronger film slate driving higher box office revenue and free cash flow.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

IMAX has been on fire lately. In the past six months alone, the company’s stock price has rocketed 40.5%, reaching $53.47 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

"Resident Evil" delivered a franchise record opening weekend that topped prerelease domestic expectations, and IMAX (IMAX) shares climbed 2.6% as the company outlined a projection for US$1.4b in worldwide box office collections in 2026. The latest move comes on top of a strong run. IMAX has delivered a year to date share price return of 50.03% and a one year total shareholder return of 65.46%, while the three and five year total shareholder returns of 179.28% and 192.11% point to momentum...

"Resident Evil" recently delivered a franchise-record opening weekend that surpassed pre-release domestic expectations, contributing to IMAX's projection of a record US$1.40 billion in worldwide box office collections for 2026. This strong performance underscores how hit titles can reinforce demand for IMAX’s premium format, supporting its broader push into higher-value theatrical experiences. We’ll now explore how this record "Resident Evil" opening fits into IMAX’s existing investment...

The Paramount Skydance plan to absorb Warner Bros Discovery has turned a legal saga into a live test of what a bigger studio machine could mean for cinema exposed stocks. A binding theatrical quota, preserved cable scale and extra US production spend all push more money and content toward screens. This piece walks through three US listed entertainment companies tied to that story and why their exposure matters for your portfolio decisions. The stocks covered next are only a sample from this...

AMC's latest debt move shifts a key deadline further into the future, but whether that buys the struggling theater chain genuine breathing room or simply delays a reckoning depends on details the market is still pricing in.

The film industry rode blockbusters like Spider Man and The Odyssey to a record for domestic ticket sales, Rentrak data show.

AMC stock is sliding back toward last week's levels while Robinhood barely flinches, and that disconnect raises a pointed question about what Friday's CEO feud was actually trading on.